EUVIMEDObjevte EUVIMED
Open access · CC BY-NC 4.0

Retrospective analysis of the tolerability and effectiveness of rimegepant for the acute treatment of migraine in adolescents

Konstantinos Tourlas iD, Sruthi Ilangovan iD, Chelsea White, Samantha L Irwin iD, Sara Pavitt iD

Headache: The Journal of Head and Face Pain · 2026-04 · 66 (4) · 829-834

DOI: 10.1111/head.70033 ↗

At a glance

Journal article in Headache: The Journal of Head and Face Pain, published online on 2026-02-06. Written by Konstantinos Tourlas and 4 co-authors. Institution: Pediatric Headache Center, Department of Pediatric Neurology, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA. Major MEDLINE topics: Migraine Disorders, Calcitonin Gene-Related Peptide Receptor Antagonists, Pyridines, Piperidines. Cited 4 times so far (Crossref); 29 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

This study aims to evaluate the tolerability and effectiveness of the off‐label use of rimegepant as acute migraine treatment in adolescents.

Background

Calcitonin gene‐related peptide (CGRP) levels are elevated during migraine attacks. Gepants, oral CGRP receptor antagonists, have demonstrated effectiveness as acute and preventive migraine treatment in adults. They are generally well tolerated with limited side effects. Their use for migraine is approved by the United States Food and Drug Administration (FDA) in adults; however, data on their use in adolescents remain limited.

Methods

This is a retrospective chart review of pediatric patients

Subjects

MeSH terms (MEDLINE)

Migraine DisordersCalcitonin Gene-Related Peptide Receptor AntagonistsPyridinesPiperidinesHumansAdolescentFemaleRetrospective StudiesMaleTreatment Outcome

Author keywords

calcitonin gene‐related peptidemigrainepediatric

Substances

Calcitonin Gene-Related Peptide Receptor Antagonistsrimegepant sulfatePyridinesPiperidines

Authors and institutions

  • Pediatric Headache Center, Department of Pediatric Neurology, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • UT Health Austin Pediatric Neurosciences at Dell Children's, Dell Children's Medical Center and UT Health Austin, Austin, Texas, USA.
  • Department of Neurology, Dell Medical School at The University of Texas at Austin, Austin, Texas, USA.
  • Department of Pediatrics, Dell Medical School at The University of Texas at Austin, Austin, Texas, USA.

ORCID profiles: Konstantinos Tourlas, Sruthi Ilangovan, Samantha L Irwin, Sara Pavitt

Cite

APA

Tourlas, K., Ilangovan, S., White, C., Irwin, S. L., & Pavitt, S. (2026). Retrospective analysis of the tolerability and effectiveness of rimegepant for the acute treatment of migraine in adolescents. Headache: The Journal of Head and Face Pain, 66(4), 829-834. https://doi.org/10.1111/head.70033

Vancouver

Tourlas K, Ilangovan S, White C, Irwin SL, Pavitt S. Retrospective analysis of the tolerability and effectiveness of rimegepant for the acute treatment of migraine in adolescents. Headache: The Journal of Head and Face Pain. 2026;66(4):829-834. doi:10.1111/head.70033

BibTeX
@article{Tourlas2026,
  author = {Tourlas, Konstantinos and Ilangovan, Sruthi and White, Chelsea and Irwin, Samantha L and Pavitt, Sara},
  title = {Retrospective analysis of the tolerability and effectiveness of rimegepant for the acute treatment of migraine in adolescents},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2026},
  volume = {66},
  number = {4},
  pages = {829--834},
  doi = {10.1111/head.70033}
}
Start for free →